Stay updated on Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.5.4, was added to the page's history, replacing the previous v3.5.3 entry.
    Difference
    0.1%
    Check dated 2026-05-15T06:52:05.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s version footer was updated from revision v3.5.2 to v3.5.3, reflecting a backend/UI software update for the ClinicalTrials.gov site rather than a change to the trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:25.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated: v3.5.0 was removed and v3.5.2 added. No user-facing content changes are indicated.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:12.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision 3.5.0 was added and Revision 3.4.3 was removed from the study record history.
    Difference
    0.1%
    Check dated 2026-03-19T06:23:54.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    New revision entry added: v3.4.3, replacing the previous v3.4.2. This is a routine site version update without changes to the study data or record content.
    Difference
    0.1%
    Check dated 2026-03-12T02:46:14.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history; removed the government-funding lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:19:24.000Z thumbnail image

Stay in the know with updates to Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial page.